1. Home
  2. NOMD vs RAPP Comparison

NOMD vs RAPP Comparison

Compare NOMD & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nomad Foods Limited

NOMD

Nomad Foods Limited

HOLD

Current Price

$9.86

Market Cap

1.4B

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$27.37

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOMD
RAPP
Founded
2014
2022
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Packaged Foods
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2015
2024

Fundamental Metrics

Financial Performance
Metric
NOMD
RAPP
Price
$9.86
$27.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$14.25
$48.50
AVG Volume (30 Days)
1.8M
298.9K
Earning Date
05-07-2026
03-10-2026
Dividend Yield
6.94%
N/A
EPS Growth
N/A
24.34
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.36
N/A
P/E Ratio
$8.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.54
$7.73
52 Week High
$20.14
$42.27

Technical Indicators

Market Signals
Indicator
NOMD
RAPP
Relative Strength Index (RSI) 29.73 44.34
Support Level $9.54 $25.40
Resistance Level $12.36 $30.10
Average True Range (ATR) 0.33 2.02
MACD -0.04 -0.35
Stochastic Oscillator 22.26 24.13

Price Performance

Historical Comparison
NOMD
RAPP

About NOMD Nomad Foods Limited

Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distributing branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream, and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: